About Our Team
Innovation through precision.
With Everest, we simplify regulatory submissions and compliance with AI-driven precision.
Our story
Everest was built to redefine how life sciences teams create critical documentation. Traditional processes are slow, manual, and complex—we knew there had to be a better way. By leveraging AI, Everest automates documentation, ensures compliance, and accelerates time to market. With built-in expert intelligence and workflow-aware automation, we empower teams to navigate regulations with speed and accuracy. Our mission is simple: streamline compliance so innovators can bring life-changing solutions to market faster.
Meet the founders
Arjun Bansal
CEO & Co-founder
Arjun's career spans research in brain-machine interfaces, building AI processors and AI sidekicks. He co-founded Nervana Systems (acquired by Intel) and XOKind, an AI travel agent startup. As VP for AI Software & Research at Intel, he launched and led several open-source AI projects and enterprise engagements—including serving as executive sponsor for healthcare AI partnerships with GE, Siemens, and Philips. Arjun’s academic background includes postdoctoral work at Boston Children’s Hospital and Harvard Medical School, a PhD in Neuroscience from Brown University, and a BS in Computer Science from Caltech.
Niklas Nielsen
CTO & Co-founder
Nik was most recently Head of Product at MosaicML (acquired by Databricks). He previously worked at Intel and Mesosphere, building distributed systems for companies like Twitter and Apple, and at Adobe on the Virtual Machines and Compilers team. He also co-founded CustomerDB, a startup applying AI to product management.
Advisors
Dr. Shaden Marzouk, MD MBA
Dr. Shaden Marzouk, MD MBA, is the CEO of GenesisCare with nearly 30 years of global healthcare experience, including leading multibillion-dollar turnarounds. She has held executive roles at HBC, Anthem, AXA, and Cardinal Health as Chief Medical Officer of the Medical Segment. A former neurosurgeon and U.S. Army Major, Dr. Marzouk earned her MBA from Duke University, worked in healthcare investment banking at Goldman Sachs, and serves on private and public company boards while advising startups.
Robin Fatzinger, RAC
Robin Fatzinger, RAC, is a seasoned executive in Clinical, Quality, and Regulatory Affairs with over 30 years of experience in the medical device industry. She currently serves as the Associate Vice President of Regulatory & Medical Affairs at Neuronetics, Inc., where she leads domestic and foreign regulatory strategy and compliance efforts. Robin has held leadership roles at Conventus Flower Orthopedics, Dune Medical Devices, Aesculap, and Teleflex Medical, among others. Her expertise spans FDA submissions, global regulatory approvals, quality assurance, compliance management, and clinical study oversight. She holds a B.S. in Biology from Muhlenberg College and an M.Ed. from Lehigh University.
Stephen Ranjan
Stephen Ranjan is a digital health executive with more than two decades of experience at the intersection of healthcare, technology, and business strategy. He is the Founder & CEO of Sentient Health, advising pharmaceutical companies and startups on applying AI and digital health across the R&D value chain, and an Entrepreneur in Residence at Memorial Sloan Kettering Cancer Center. He previously spent seven years at Roche, most recently as Global Head of Digital Health, leading digital innovation strategy across oncology, neuroscience, and ophthalmology. Earlier, he held commercial and innovation leadership roles at Merck and Johnson & Johnson's Janssen Healthcare Innovation, and spent nearly a decade at Epic building enterprise EHR systems.
Mark Spizer
Mark Spizer is a biotech entrepreneur and investor with nearly two decades of experience across life sciences, M&A, and strategy. He is the Co-Founder & COO of Gusto Global, which develops microbiome-based therapies for conditions including IBD, neuroinflammation, and cancer immunotherapy, where he leads operations, financing, and product development. He is also a Partner at Ruddigore Partners, a multi-family office investing in early-stage healthcare — diagnostics, medtech, and biotech — and a Managing Director at Fennebresque & Co., an investment bank focused on M&A and corporate finance in healthcare and technology.
Our investors
We're backed by the best.
Everest is backed by leading AI and dev tool investors, including Quiet Capital, TQ Ventures, and Essence VC, along with angels who are the founders/CEOs of dbt Labs, MosaicML, Modal, Okta, AngelList, Vicarious, Crusoe Cloud, Echo AI, Blue River, Sonatic, d2iq, Crux, and MLOps.community.
